Activity of cabozantinib (cabo) after PD-1/PD-L1 immune checkpoint blockade (ICB) in metastatic clear cell renal cell carcinoma (mccRCC) Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • McGregor, BA
  • Lalani, Aly-Khan
  • Xie, W
  • Steinharter, JA
  • Martini, DJ
  • Nuzzo, PV
  • Martinez Chanza, N
  • Harshman, LC
  • Bilen, MA
  • Choueiri, TK

publication date

  • October 2018